Social Media Ideas for /Feature/Innovation-Rx

<![CDATA[The Ron Lanton Report: From Innovation to Infrastructure]]>

<![CDATA[TrumpRx Expands to Offer Generic Medications]]>

Success Stories: AI-Powered Pharmaceutical Innovation

As AI (artificial intelligence), advanced manufacturing, and biotechnology continue to evolve, universities and industry leaders are forming major partnerships to accelerate the fu...

Virtual care tech companies launch 'out-of-the-box' RPM tool for pharmacies

The program's goal is to empower pharmacies, particularly independent ones in rural areas, to oversee and support chronic care patients between scheduled office visits.

Evernorth unveils new AI-powered specialty pharmacy program, Pharmacy Forward

Evernorth has unveiled a new specialty pharmacy program that leans on AI to support a better experience for patients with complex conditions.

<![CDATA[Evolving Beyond Launch Postmortems to Real-Time Optimization]]>

<![CDATA[“AI as Reinvention”: Transforming the Business of Medicine]]>

<![CDATA[China Pharma Trends: Premium Pricing and Priority Access for True Innovations]]>

The hidden innovation system behind drug repurposing 

Delve into the hidden innovation system of drug repurposing. When patents expire and commercial value fades, a new wave of research starts. The post The hidden innovation system be...

Healthpro’s innovation den announces winners

TORONTO – HealthPRO Canada, in partnership with the National Healthcare Innovation Council, is proud to recognize the winners of the inaugural Healthcare Innovation Den, a national...

Next Generation Biopharma Innovation

In a quest to provide more relevant translational data, traditional in vivo models join forces with new approach methodologies. The post Next Generation Biopharma Innovation appear...

<![CDATA[Pharmaceutical Executive Daily: AI as Reinvention]]>

Why Axsome Stock Has Doubled In Nine Months

In this week’s edition of InnovationRx, we look at Axsome’s growing pipeline, HistoSonics innovative cancer treatment, state litigation over Medicaid work requirements, and more.

<![CDATA[An End-to-End Approach to Specialty Patient Services]]>

Innovation alone is no longer enough in biopharma

In biopharma, the next edge may come from the systems that turn discovery into scale.

Canadians can now get digital prescriptions for 'generic Ozempic'

Hims & Hers has started offering eligible customers personalized treatment plans starting at $149/month

Why one health system invested in its PBM as GLP-1 costs surged

How RxSense helped a health system invest in its own PBM and take control of rising GLP-1 costs.

<![CDATA[Nuvation Bio’s Approach to Building a Compelling Narrative]]>

<![CDATA[What Specialty Access Looks Like When It’s Built to Scale]]>

Life Sciences: Where Innovation Meets Risk

The life sciences industry, long known for its innovation and complexity, continues to evolve at a remarkable pace. From AI-powered diagnostics to wearable monitors and at-home gen...

<![CDATA[Driving Progress]]>

<![CDATA[What Do You See as The Next Phase of Obesity Innovation?]]>

Big Pharma Is Buying Innovation Again. Have They Given Up on Their Own R&D?

Big Pharma Is Buying Innovation Again. Have They Given Up on Their Own R&D? Anonymous (not verified) Wed, 06/24/2026 - 03:01 pharmagather item url Big...

Innovation Fatigue in Healthcare Is Real, Here’s How to Avoid It

The following is a guest article by Melissa Powell, President & Chief Operating Officer at The Allure Group Healthcare has never lacked innovation. The industry is currently ex...